RecruitingPhase 4NCT06803992

Induction of Labor - Comparison Propess With Prostaglandin E2 Vaginal Gel and Balloon Catheter

Induction of Labor in Women With Unfavorable Cervix at Term - Comparison of Propess Versus Prostaglandin E2 Vaginal Gel and Extra-amniotic Balloon Catheter


Sponsor

HaEmek Medical Center, Israel

Enrollment

140 participants

Start Date

Apr 6, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

One of every four births in the Western world is induced, usually due to the risk of maternal and fetal morbidity. There are several methods of labor induction, pharmacological and mechanical. In cases of unfavorable cervix (Bishop score is below 5), cervical ripening can be induced by either prostaglandins E2 (slow release 10 mg dinoprostone insert (propess) or vaginal gel 1-2 mg) or mechanically by Foley catheter balloon (FCB). The efficacy of labor induction of propess versus vaginal gel combined with FCB was not studied previously. The goal of this randomized controlled trial is to compare the efficacy of propess versus PGE2 vaginal gel combined with FCB in women with singletons undergoing labor induction at term. The main question it aims to answer is to compare the time from the beginning of labor induction until delivery.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 60 Years

Inclusion Criteria6

  • Pregnant women at term (37 weeks of gestation or more) with singleton
  • pregnancies that are intended for IOL.
  • Initial bishop score <5
  • No contraindications to receive either treatment.
  • Women who will give informed consent to be included in the study.
  • Women at or over the age of 18.

Exclusion Criteria9

  • Women with a known hypersensitivity or contraindications to Propess / PGE2.
  • Parity 5 or more
  • Labor contractions more than 4 in 20 min
  • Glaucoma
  • History of previous uterine surgery
  • Hypersensitivity to prostaglandins
  • Vaginal delivery is contraindicated
  • Active cardiac, renal, pulmonary, or hepatic disease
  • Severe asthma or pulmonary disease

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGDinoprostone vaginal insert

Described in the arm descriptions

COMBINATION_PRODUCTDinoprostone gel and Foley catheter balloon

Described in the arm descriptions


Locations(1)

Emek medical center

Afula, Israel

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06803992


Related Trials